Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • tarias
    Member
    • Sep 2011
    • 10

    De novo genome assembly question: which assembly should I use?

    I have sequenced two individuals and done three libraries per individual each with a different insert size (170, 500, 800).Using flow citometry I know this genome is 332MB. Also I know is diploid and the genetic variation is not to high. I have done different assemblies for a this plant genome and found this two were the best:

    One Individual
    3 libraries
    Insert size 170, 500, 800
    Number of clean reads 70,287,710
    Number of contigs 134,557
    Mean N50 length (bp) 5,050
    BUSCO 78.54


    Two Individuals
    2 individuals
    6 libraries
    Insert size 170, 500, 800
    Number of clean reads 209,022,970
    Number of contigs 446,608
    Mean N50 length (bp) 4,010.65
    BUSCO 76.38

    I then ran PEP_SCAFFOLDER in this two alignments and got this

    One Individual
    3 libraries


    Main genome scaffold total: 136339
    Main genome scaffold sequence total: 189.946 MB
    Main genome contig N/L50: 17091/2.413 KB

    Two Individuals
    2 individuals
    6 libraries


    Main genome scaffold total: 444336
    Main genome scaffold sequence total: 332.652 MB
    Main genome contig N/L50: 83374/706

    I have two questions:
    1. Would you annotate any of these two genomes?
    2. Which one would you annotate and why?

    Thanks,
    Tatiana
  • ctseto
    Member
    • Oct 2013
    • 44

    #2
    Annotation may reveal what's not there, esp if you know from exp that a given gene is present (eg someone PCR/subcloned ). Guessing eukaryote and that you may have hit some contigs that are repeat heavy (eg contig is pure repeat), and perhaps that your library isn't traversing those repeats?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    211 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    78 views
    0 reactions
    Last Post SEQadmin2  
    Working...